In 1989, a report was published demonstrating for the first time (emphasis added) that IL-6 addition to cell culture medium enhanced motility as well as the transition from cuboidal to fibroblastoid-like morphology of ER+ breast cancer cells. Here, IL6 is linked to breast carcinoma.